Login

Ben McMillan, CIO and founder of IDX Digital Assets, discusses market insights in an interview with CNBC. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
3 Ways to Jumpstart Your Finances in the New Year | Ben Smith - FOUNDER & FINANCIAL PLANNER of Cove Financial Planning, LLC
00:10:00
Do you WANT Venture Capital|Andrew Goldner, Co-Founder, GrowthX
00:10:00
The Evolution of Hedge Funds and the Future of Asset Management | Milken Institute Panel Discussion
00:10:00
Guaranteeing Assured Quality of Service for Telecom Customers | Jerry Li, CEO, PCCW Ltd8:HKG
00:10:00
invests in innovative fintech companies in emerging markets|Monica Brand Engel,Co-founder and Managing Partner,Quona Capital
00:10:00
Building a Global VC firm & Learnings From Indian Founders|Vinny Pujji,Managing Partner,Left Lane Capital
00:00:00
Philip Toleikis, Ph.D., CEO and President, Sernova Corp
00:10:00
B&W's ClimateBright™: Building a Clean Energy Future | Kenneth Young - CEO of Babcock & Wilcox
00:10:00
At The Top: Accor CEO Sébastien Bazin | Sébastien Bazin, CEO , Accor SA.
00:10:00
Roy Global's Kin P Discusses Innovative Separation Technologies and New Developments in Mining at DLC Mining Week 2024
00:10:00
Impact of South Africa’s Election on Local Markets: Insights from Everest Wealth CEO Thys van Zyl | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:00:00
Biophytis sees positive data from PHASE 2-3 COVA CLINICAL STUDY of Sarconeos - Stanislas Veillet , CEO, Biophytis

© 2017 - Neuhu+